Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO – Get Free Report) was the recipient of a significant decrease in short interest in October. As of October 15th, there was short interest totalling 1,020,000 shares, a decrease of 63.6% from the September 30th total of 2,800,000 shares. Approximately 4.7% of the company’s stock are short sold. Based on an average trading volume of 1,210,000 shares, the short-interest ratio is currently 0.8 days.
Wall Street Analyst Weigh In
Separately, Benchmark reaffirmed a “speculative buy” rating and set a $2.00 price target on shares of Cardio Diagnostics in a research report on Tuesday, August 27th.
Get Our Latest Stock Analysis on CDIO
Cardio Diagnostics Stock Performance
Cardio Diagnostics (NASDAQ:CDIO – Get Free Report) last released its quarterly earnings data on Monday, August 12th. The company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.07. Cardio Diagnostics had a negative net margin of 22,358.43% and a negative return on equity of 312.97%. The firm had revenue of $0.01 million for the quarter, compared to analyst estimates of $0.13 million. As a group, equities research analysts predict that Cardio Diagnostics will post -0.55 EPS for the current year.
Cardio Diagnostics Company Profile
Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.
Featured Stories
- Five stocks we like better than Cardio Diagnostics
- 3 Monster Growth Stocks to Buy Now
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Following Congress Stock Trades
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Cardio Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardio Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.